Differences in clinical manifestations of imported versus autochthonous leptospirosis in Austria and Germany

American Journal of Tropical Medicine and Hygiene

Volumn 83, Issue 2, 2010, Pages 326-335

  Hoffmeister, Bodo ^a   Peyerl Hoffmann, Gabriele ^b   Pischke, Sven ^c   Zollner Schwetz, Ines ^d   Krause, Robert ^d   Müller, Matthias C ^e   Graf, Angelika ^a   Kluge, Stefan ^f   Burchard, Gerd D ^f,g   Kern, Winfried V ^b   Suttorp, Norbert ^a   Cramer, Jakob P ^f,g  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY OF FREIBURG   (Germany)

^c HANNOVER MEDICAL SCHOOL   (Germany)

^d MEDICAL UNIVERSITY OF GRAZ   (Austria)

^e UNIVERSITY OF MUNICH   (Germany)

^f UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^g BERNHARD NOCHT INSTITUTE FOR TROPICAL MEDICINE   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; AUSTRIA; CLINICAL ASSESSMENT; CLINICAL FEATURE; CONTROLLED STUDY; DEATH; DISEASE CLASSIFICATION; DISEASE SEVERITY; FATALITY; FEMALE; GERMANY; HUMAN; JAUNDICE; LEPTOSPIROSIS; MAJOR CLINICAL STUDY; MALE; PROGNOSIS; RISK FACTOR;

ADOLESCENT; ADULT; AGED; AUSTRIA; FEMALE; GERMANY; HUMANS; LEPTOSPIROSIS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; RISK FACTORS; SEASONS; TIME FACTORS; TRAVEL; YOUNG ADULT;

EID: 77955599596     PISSN: 00029637     EISSN: None     Source Type: Journal    
DOI: 10.4269/ajtmh.2010.10-0040     Document Type: Article

References (40)

1. 1999. Leptospirosis worldwide, 1999. Wkly Epidemiol Rec 74: 237-242.
2. Levett PN, 2001. Leptospirosis. Clin Microbiol Rev 14: 296-326.
3. Bharti AR, Nally JE, Ricaldi JN, Matthias MA, Diaz MM, Lovett MA, Levett PN, Gilman RH, Willig MR, Gotuzzo E, Vinetz JM, 2003. Leptospirosis: a zoonotic disease of global importance. Lancet Infect Dis 3: 757-771.
4. Peter G, 1982. Leptospirosis: a zoonosis of protean manifestations. Pediatr Infect Dis 1: 282-288.
5. Turner LH, 1967. Leptospirosis. I. Trans R Soc Trop Med Hyg 61: 842-855.
6. Bovet P, Yersin C, Merien F, Davis CE, Perolat P, 1999. Factors associated with clinical leptospirosis: a population-based case-control study in the Seychelles (Indian Ocean). Int J Epidemiol 28: 583-590.
7. Ashford DA, Kaiser RM, Spiegel RA, Perkins BA, Weyant RS, Bragg SL, Plikaytis B, Jarquin C, De Lose Reyes JO, Amador JJ, 2000. Asymptomatic infection and risk factors for leptospirosis in Nicaragua. Am J Trop Med Hyg 63: 249-254. (Pubitemid 32537558)
8. Paganin F, Bourdin A, Dalban C, Courtin JP, Poubeau P, Borgherini G, Michault A, Sally JC, Tixier F, Genin R, Arvin-Berod C, 2007. Leptospirosis in Reunion Island (Indian Ocean): analysis of factors associated with severity in 147 confirmed cases. Intensive Care Med 33: 1959-1966.
9. Wang CN, John L, Chang TF, Cheng WJ, Lou MY, Hung AT, 1965. Studies on anicteric leptospirosis. I. Clinical manifestations and antibiotic therapy. Chin Med J (Engl) 84: 283-291.
10. Park SK, Lee SH, Rhee YK, Kang SK, Kim KJ, Kim MC, Kim KW, Chang WH, 1989. Leptospirosis in Chonbuk Province of Korea in 1987: a study of 93 patients. Am J Trop Med Hyg 41: 345-351.
11. Zaki SR, Shieh WJ, 1996. Leptospirosis associated with outbreak of acute febrile illness and pulmonary haemorrhage, Nicaragua, 1995. The Epidemic Working Group at Ministry of Health in Nicaragua. Lancet 347: 535-536.
12. Trevejo RT, Rigau-Perez JG, Ashford DA, McClure EM, Jarquin-Gonzalez C, Amador JJ, de los Reyes JO. Gonzalez A, Zaki SR, Shieh WJ, McLean RG, Nasci RS, Weyant RS, Bolin CA, Bragg SL, Perkins BA, Spiegel RA, 1998. Epidemic leptospirosis associated with pulmonary hemorrhage-Nicaragua, 1995. J Infect Dis 178: 1457-1463.
13. Segura ER, Ganoza CA, Campos K, Ricaldi JN, Torres S, Silva H, Cespedes MJ, Matthias MA, Swancutt MA, Lopez Linan R, Gotuzzo E, Guerra H, Gilman RH, Vinetz JM, 2005. Clinical spectrum of pulmonary involvement in leptospirosis in a region of endemicity, with quantification of leptospiral burden. Clin Infect Dis 40: 343-351.
14. Kuriakose M, Eapen CK, Paul R, 1997. Leptospirosis in Kolenchery, Kerala, India: epidemiology, prevalent local serogroups and serovars and a new serovar. Eur J Epidemiol 13: 691-697.
15. Plank R, Dean D, 2000. Overview of the epidemiology, microbiology, and pathogenesis of Leptospira spp. in humans. Microbes Infect 2: 1265-1276.
16. Daher E, Zanetta DM, Cavalcante MB, Abdulkader RC, 1999. Risk factors for death and changing patterns in leptospirosis acute renal failure. Am J Trop Med Hyg 61: 630-634.
17. Ko AI, Galvao Reis M, Ribeiro Dourado CM, Johnson WD Jr, Riley LW, 1999. Urban epidemic of severe leptospirosis in Brazil. Salvador Leptospirosis Study Group. Lancet 354: 820-825.
18. Dupont H, Dupont-Perdrizet D, Perie JL, Zehner-Hansen S, Jarrige B, Daijardin JB, 1997. Leptospirosis: prognostic factors associated with mortality. Clin Infect Dis 25: 720-724.
19. Panaphut T, Domrongkitchaiporn S, Thinkamrop B, 2002. Prognostic factors of death in leptospirosis: a prospective cohort study in Khon Kaen, Thailand. Int J Infect Dis 6: 52-59.
20. Doudier B, Garcia S, Quennee V, Jarno P, Brouqui P, 2006. Prognostic factors associated with severe leptospirosis. Clin Microbiol Infect 12: 299-300.
21. Marotto PC, Nascimento CM, Eluf-Neto J, Marotto MS, Andrade L, Sztajnbok J, Seguro AC, 1999. Acute lung injury in leptospirosis: clinical and laboratory features, outcome, and factors associated with mortality. Clin Infect Dis 29: 1561-1563.
22. Lopes AA, Costa E, Costa YA, Bina JC, Sacramento E, 2001. The association between serum potassium at hospital admission and the case-fatality rate of leptospirosis in men. Rev Inst Med Trop Sao Paulo 43: 217-220.
23. Spichler AS, Vilaca PJ, Athanazio DA, Albuquerque JO, Buzzar M. Castro B, Seguro A, Vinetz JM, 2008. Predictors of lethality in severe leptospirosis in urban Brazil. Am J Trop Med Hyg 79: 911-914.
24. Pappachan MJ, Mathew S, Aravindan KP, Khader A, Bharghavan PV. Kareem MM, Tuteja U, Shukla J, Batra HV, 2004. Risk factors for mortality in patients with leptospirosis during an epidemic in northern Kerala. Natl Med J India 17: 240-242.
25. Tantitanawat S, Tanjatham S, 2003. Prognostic factors associated with severe leptospirosis. J Med Assoc Thai 86: 925-931.
26. Esen S, Sunbul M, Leblebicioglu H, Eroglu C, Turan D, 2004. Impact of clinical and laboratory findings on prognosis in leptospirosis. Swiss Med Wkly 134: 347-352.
27. Jansen A, Schoneberg I, Frank C, Alpers K, Schneider T, Stark K, 2005. Leptospirosis in Germany, 1962-2003. Emerg Infect Dis 11: 1048-1054.
28. van Crevel R, Speelman P, Gravekamp C, Terpstra WJ, 1994. Leptospirosis in travelers. Clin Infect Dis 19: 132-134.
29. Benzler J, Krause G, 2004. On the 2004 edition of case definitions for the surveillance of notifiable infectious diseases in Germany. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz 47: 141-146.
30. Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P, 2004. Acute renal - definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group. Crit Care 8: R204-R212.
31. Levy MM, Fink MP, Marshall JC, Abraham E, Angus D, Cook D, Cohen J, Opal SM, Vincent JL, Ramsay G, 2003. 2001 SCCM/ESICM/ACCP/ATS/SIS International Sepsis Definitions Conference. Crit Care Med 31: 1250-1256. (Pubitemid 36444440)
32. Bernard GR, Artigas A, Brigham KL, Carlet J, Falke K, Hudson L, Lamy M, Legall JR, Morris A, Spragg R, 1994. The American-European Consensus Conference on ARDS. Definitions, mechanisms, relevant outcomes, and clinical trial coordination. Am J Respir Crit Care Med 149: 818-824.
33. Ren SX, Fu G, Jiang XG, Zeng R, Miao YG, Xu H, Zhang YX, Xiong H, Lu G, Lu LF, Jiang HQ, Jia J, Tu YF, Jiang JX, Gu WY, Zhang YQ, Cai Z, Sheng HH, Yin HF, Zhang Y, Zhu GF, Wan M, Huang HL, Qian Z, Wang SY, Ma W, Yao ZJ, Shen Y, Qiang BQ, Xia QC, Guo XK, Danchin A, Saint Girons I, Somerville RL, Wen YM, Shi MH, Chen Z, Xu JG, Zhao GP, 2003. Unique physiological and pathogenic features of Leptospira interrogans revealed by whole-genome sequencing. Nature 422: 888-893.
34. Ko AI, Goarant C, Picardeau M, 2009. Leptospira: the dawn of the molecular genetics era for an emerging zoonotic pathogen. Nat Rev Microbiol 7: 736-747.
35. Katz AR, Ansdell VE, Effler PV, Middleton CR, Sasaki DM, 2001. Assessment of the clinical presentation and treatment of 353 cases of laboratory-confirmed leptospirosis in Hawaii, 1974-1998. Clin Infect Dis 33: 1834-1841.
36. Jansen A, Stark K, Schneider T, Schoneberg I, 2007. Sex differences in clinical leptospirosis in Germany: 1997-2005. Clin Infect Dis 44: e69-e72.
37. Miranda KA, Vasconcelos LR, Coelho LC, Lima Filho JL, Cavalcanti MS, Moura P, 2009. High levels of serum mannose-binding lectin are associated with the severity of clinical signs of leptospirosis. Braz J Med Biol Res 42: 353-357.
38. Viriyakosol S, Matthias MA, Swancutt MA, Kirkland TN, Vinetz JM, 2006. Toll-like receptor 4 protects against lethal Leptospira interrogans serovar icterohaemorrhagiae infection and contributes to in vivo control of leptospiral burden. Infect Immun 74: 887-895.
39. Merien F, Truccolo J, Rougier Y, Baranton G, Perolat P, 1998. In vivo apoptosis of hepatocytes in guinea pigs infected with Leptospira interrogans serovar icterohaemorrhagiae. FEMS Microbiol Lett 169: 95-102.
40. Guidugli F, Castro AA, Atallah AN, 2000. Antibiotics for treating leptospirosis. Cochrane Database Syst Rev CD001306.